Nucleophosmin Protein (npm) Mutants, Corresponding Gene Sequences And Uses Thereof


The full document isn't yet available to us from the patent office.


The invention relates to new nucleophosmin protein (NPM) mutants, corresponding gene sequences and relative uses thereof for diagnosis, monitoring of minimal residual disease; prognostic evaluation and therapy of the acute myeloid leukaemia (AML).


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2008
  • Application: Oct 28, 2005
    EP EP 07021463 A
  • Priority: Oct 28, 2005
    EP EP 05813231 A
  • Priority: Oct 29, 2004
    IT IT RM20040534 A

Sign in to the Lens